Evidence map›Paper›PMID 41323978›Full record

ArticleFrontiers in endocrinology2025

Case Report: Novel likely pathogenic

Rustam Salimkhanov, Marina Utkina, Hanum Bagirova, Anna Eremkina, Ekaterina Prosandeeva, Sergey Popov, Victoria Zakharova, Vasiliy Petrov, Alexey Novoselov, Ekaterina Bondarenko and 3 more

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Rustam SalimkhanovDepartment of Parathyroid Pathology and Mineral Disorders, Endocrinology Research Centre, Moscow, Russia.
Marina UtkinaLaboratory of General, Molecular and Population Genetics, Endocrinology Research Centre, Moscow, Russia.
Hanum BagirovaDepartment of Parathyroid Pathology and Mineral Disorders, Endocrinology Research Centre, Moscow, Russia.
Anna EremkinaDepartment of Parathyroid Pathology and Mineral Disorders, Endocrinology Research Centre, Moscow, Russia.
Ekaterina ProsandeevaLaboratory of General, Molecular and Population Genetics, Endocrinology Research Centre, Moscow, Russia.
Sergey PopovLaboratory of General, Molecular and Population Genetics, Endocrinology Research Centre, Moscow, Russia.
Victoria ZakharovaLaboratory of General, Molecular and Population Genetics, Endocrinology Research Centre, Moscow, Russia.
Vasiliy PetrovLaboratory of General, Molecular and Population Genetics, Endocrinology Research Centre, Moscow, Russia.
Alexey NovoselovLaboratory of General, Molecular and Population Genetics, Endocrinology Research Centre, Moscow, Russia.
Ekaterina BondarenkoLaboratory of Pathomorphology, Endocrinology Research Centre, Moscow, Russia.
Daria PastukhovaLaboratory of Pathomorphology, Endocrinology Research Centre, Moscow, Russia.
Lyudmila RozhinskayaDepartment of Osteoporosis and Osteopathies, Endocrinology Research Centre, Moscow, Russia.
Natalia MokryshevaDirectorate, Endocrinology Research Centre, Moscow, Russia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multiple endocrine neoplasia type 1 (MEN-1; OMIM 131100) is a rare, autosomal dominant syndrome caused by heterozygous inactivating mutations in the

Indexed as

MosaicismMultiple Endocrine Neoplasia Type 1MutationProto-Oncogene ProteinsAdultFemaleGerm-Line MutationHumansMaleMiddle AgedPancreatic NeoplasmsPedigreePituitary NeoplasmsMEN1 protein, humanProto-Oncogene Proteinsgenetic testinghigh-coverage NGSmosaic mutationmultiple endocrine neoplasia type 1phenocopy

Identifiers

PMID41323978
PMCPMC12660097

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.